References
- Amato, L., Davoli, M., Perucci, C. A., Ferri, M., Faggiano, F., & Mattick, R. P. (2005). An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment, 28, 321–329. doi:10.1016/j.jsat.2005.02.007
- Berends, L., Larner, A., & Lubman, D. I. (2015). Delivering opioid maintenance treatment in rural and remote settings. Australian Journal of Rural Health, 23, 201–206. doi:10.1111/ajr.12217
- Cooper, S., & Nielsen, S. (2017). Stigma and social support in pharmaceutical opioid treatment populations: A scoping review. International Journal of Mental Health and Addiction, 15, 452–469. doi:10.1007/s11469-016-9719-6
- Day, C., Conroy, E., Lowe, J., Page, J., & Dolan, K. (2006). Patterns of drug use and associated harms among rural injecting drug users: Comparisons with metropolitan injecting drug users. Australian Journal of Rural Health, 14, 120–125. doi:10.1111/j.1440-1584.2006.00775.x
- Digiusto, E., & Treloar, C. (2007). Equity of access to treatment, and barriers to treatment for illicit drug use in Australia. Addiction, 102, 958–969. doi:10.1111/j.1360-0443.2007.01842.x
- Drugs and Poisons Regulation Branch. (2016). Policy for maintenance pharmacotherapy for opioid dependence. In Ed., SERVICES, D. O. H. A. H. Melbourne, Australia: State of Victoria, Department of Health and Human Services.
- Fraser, S., Valentine, K., Treloar, C., & Macmillan, K. (2007). Methadone maintenance treatment in New South Wales and Victoria: Takeaways, diversion and other key issues. Sydney: National Centre in HIV Social Research, University of New South Wales.
- Fusch, P. I., & Ness, L. R. (2015). Are we there yet? Data saturation in qualitative research. The Qualitative Report, 20, 1408.
- King, T., Berends, L., & Ritter, A. (2013). Victorian pharmacotherapy review. Sydney, Australia:National Drug and Alcohol Research Centre.
- Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. The Cochrane Library.Milton Qld, Australia:John Wiley & Sons.
- New South Wales Department of Health. (2011). Opioid treatment program: Clinical guidelines for methadone and buprenorphine treatment. North Sydney, Australia: NSW Department of Health.
- Peterson, G., Northeast, S., Jackson, S., & Fitzmaurice, K. (2007). Harm minimization strategies: Opinions of health professionals in rural and remote Australia. Journal of Clinical Pharmacy and Therapeutics, 32, 497–504. doi:10.1111/j.1365-2710.2007.00857.x
- Qrs International Pty Ltd. (2015). NVivo qualitative data analysis software (11 ed). Melbourne, Australia: QSR International Pty Ltd.
- Ritter, A., & Chalmers, J. (2009). Polygon: The many sides to the Australian opioid pharmacotherapy maintenance system. Canberra, Australia:Australian National Council on Drugs.
- Sigmon, S. C. (2014). Access to treatment for opioid dependence in rural America: Challenges and future directions. JAMA psychiatry, 71, 359–360. doi:10.1001/jamapsychiatry.2013.4450
- Strong, K., & Strong, K. 1998. Health in rural and remote Australia: The first report of the Australian Institute of Health and Welfare on rural health, Australian Institute of Health and Welfare Canberra.
- Tanner, G., Bordon, N., Conroy, S., & Best, D. (2011). Comparing methadone and Suboxone in applied treatment settings: The experiences of maintenance patients in Lanarkshire. Journal of Substance Use, 16, 171–178. doi:10.3109/14659891.2010.526480
- World Health Organization. (2004). WHO/UNODC/UNAIDS position paper: Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. WHO/UNODC/UNAIDS position paper: Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention.
- World Health Organization. (2009). Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva, Switzerland: Author.